Plain-English translation of NCT05931419 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →The RECOVER study is comparing two common treatments for high-risk prostate cancer: robot-assisted surgery to remove the prostate, or external beam radiation therapy (sometimes combined with hormone therapy). Doctors want to understand which treatment works better, causes fewer side effects, and helps men live longer and maintain a better quality of life after treatment.
Right now, doctors don't have clear evidence about which treatment is best for men with advanced prostate cancer. Hospitals use both approaches differently, and men often don't know which option might be better for them. This study aims to provide that missing information so doctors and patients can make smarter, more informed treatment decisions together.
You likely qualify if…
You likely don't qualify if…
You would be assigned to receive either robot-assisted surgery to remove your prostate or external beam radiation therapy (with or without hormone therapy), depending on what's best for your situation. Your care team will monitor you over time to track how well the treatment works, how it affects your quality of life, and whether your cancer stays controlled. You'll likely have regular follow-up visits, imaging scans, and blood tests as part of the study.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Netherlands